AddLife AB engages in the ownership and acquisition of firms in niche segments under the healthcare sector. The company is headquartered in Stockholm, Stockholm and currently employs 2,322 full-time employees. The company went IPO on 2015-03-16. The firm markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The firm operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The firm operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
Follow-Up Questions
ADDLY hissesinin fiyat performansı nasıl?
ADDLY 'in mevcut fiyatı $0 'dir, son işlem günde 0% decreased etti.
AddLife AB için ana iş temaları veya sektörler nelerdir?
AddLife AB Life Sciences Tools & Services endüstrisine ait ve sektör Health Care 'dir
AddLife AB 'in piyasa değerlemesi nedir?
AddLife AB 'in mevcut piyasa değerlemesi $NaN 'dir
AddLife AB al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 3 analist AddLife AB için analist derecelendirmeleri gerçekleştirdi, bunlar 1 güçlü al, 3 al, 2 tut, 0 sat ve 1 güçlü sat içermektedir
